Subscribe Us

header ads

Recents

header ads

Precision Medicine Market Size To Hit US$ 175.64 Billion By 2030

Precedence Research - March 01, 2023

The global precision medicine market size is expected to hit around USD 175.64 billion by 2030 and progressing a CAGR of 11.5% over the forecast period 2022 to 2030.

Precision Medicine Market Size 2020 to 2030

The on precision medicine Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1085

Report Scope of the Precision Medicine Market

Report CoverageDetails
Market SizeUSD 175.64 Billion by 2030
Growth RateCAGR of 11.5% from 2022 to 2030
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2021
Forecast Period2022 to 2030
Segments CoveredTechnology, Application, End User, Sequencing Technology, Product, Route of Administration, Drugs, Region

A recent report provides crucial insights along with application based and forecast information in the Global Precision medicine Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Precision medicine market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Precision medicine market are included as given below:

Precision medicine Market Key Players

  • Biocrates Life Sciences
  • Tepnel Pharma Services
  • Novartis
  • Qiagen
  • Quest Diagnostics
  • Menarini Silicon Biosystems
  • NanoString Technologies
  • Eagle Genomics
  • Pfizer
  • Intomics
  • Roche
  • Teva Pharmaceutical

Market Segments

 By Technology

  • Bioinformatics
  • Big Data Analytics
  • Drug Discovery
  • Gene Sequencing
  • Companion Diagnostics
  • Others

By Application

  • CNS
  • Immunology
  • Oncology
  • Respiratory
  • Others

By End-Use

  • Diagnostic Companies
  • Pharmaceutical Companies
  • Healthcare IT companies
  • Others

By Sequencing Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By Product

  • Consumables
  • Instruments
  • Services

By Route of Administration

  • Oral
  • Injectable

By Drugs

  • Alectinib
  • Osimertinib
  • Mepolizumab
  • Aripiprazole Lauroxil
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Report Objectives

  • To define, describe, and forecast the global precision medicine market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the precision medicine market

Table of Content

 Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Precision Medicine Market, By Technology

7.1. Precision Medicine Market, by Technology Type, 2021-2030
7.1.1. Bioinformatics
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Big Data Analytics
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Drug Discovery
7.1.3.1. Market Revenue and Forecast (2019-2030)
7.1.4. Gene Sequencing
7.1.4.1. Market Revenue and Forecast (2019-2030)
7.1.5. Companion Diagnostics
7.1.5.1. Market Revenue and Forecast (2019-2030)
7.1.6. Others
7.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Precision Medicine Market, By Application

8.1. Precision Medicine Market, by Application, 2021-2030
8.1.1. CNS
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Immunology
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Oncology
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Respiratory
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Precision Medicine Market, By End-Use

9.1. Precision Medicine Market, by End-Use, 2021-2030
9.1.1. Diagnostic Companies
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Pharmaceutical Companies
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Healthcare IT companies
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Precision Medicine Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Technology (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.5.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.7.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.7.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.7.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4.3. Market Revenue and Forecast, by End-Use (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.5.3. Market Revenue and Forecast, by End-Use (2019-2030)

Chapter 11. Company Profiles

11.1. Biocrates Life Sciences
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Tepnel Pharma Services
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Novartis
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Qiagen
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Quest Diagnostics
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Menarini Silicon Biosystems
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. NanoString Technologies
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Eagle Genomics
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Pfizer
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Intomics
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Roche
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Teva Pharmaceutical
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments